Home > Insider Trading > Filing (0001102624-14-000125)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1473579	Boston Therapeutics Inc.	BTHE	Pharmaceutical Preparations (2834)	270801073

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593784	B Jonathan Rome	178 West Saddle River Road Saddle River NJ 07458		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-13	1,250,000	$0.50	1,258,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2012-11-13	625,000	$0.00	625,000	$1.00
Common Stock	Stock Options	Disposition	2013-09-30	2,500,000	$0.00	2,500,000	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
625,000	2012-11-13	2017-11-13	No	4	P	Direct
2,500,000		2017-11-01	No	4	J	Direct

Footnotes

As disclosed in Mr. Rome's Form 3, Mr. Rome was initially issued options to purchase 5,000,000 shares of common stock, vesting with respect to 416,667 shares on the date of grant (November 8, 2012) and quarterly in increments of 416,667 shares with the first installment vesting on March 31, 2013 and the final installment vesting on September 30, 2015. Mr. Rome's employment with the Issuer terminated without cause on September 30, 2013, Under the terms of the Option, the option will continue to vest quarterly through March 31, 2014, bringing the total number of vested shares at that time to 2,500,000 with the rest of the options being forfeited.